Statins: A Panacea to Reduce Mortality in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma?

Liver Transpl. 2022 Mar;28(3):357-358. doi: 10.1002/lt.26381. Epub 2021 Dec 26.

Authors

Debbie L Shawcross¹, Abid Suddle

Affiliation

¹ Institute of Liver StudiesSchool of Immunology and Microbial SciencesFaculty of Life Sciences and Medicine King's College London London UK Institute of Liver Studies King's College Hospital National Health Service Foundation Trust London UK.

PMID: 34837475
DOI: 10.1002/lt.26381

No abstract available

Publication types

Editorial

MeSH terms

Carcinoma, Hepatocellular*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Liver Neoplasms*
Liver Transplantation* / adverse effects
Retrospective Studies

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors